Literature DB >> 11242814

A case of endobronchial actinomycosis.

S L Jin1, H P Lee, J I Kim, J Y Chin, S J Choi, M Joo, H K Yum.   

Abstract

Actinomycosis is an infectious disease caused by certain Actinomyces species. Actinomyces are Gram-positive, non-spore forming organisms characterized by obligate or facultative anaerobic rods that normally inhabit anaerobic niches of the human oral cavity. Cervicofacial, abdominal, pelvic and thoracic infections of Actinomyces are not uncommon, but endobronchial actinomycosis is rarely reported. Endobronchial actinomycosis can be misdiagnosed as unresolving pneumonia, endobronchial lipoma or malignancies. Endobronchial actinomycosis should be included in the differential diagnosis of any endobronchial mass. We report a case of a 43-year-old man who presented with a productive cough and pulmonary consolidation at the right lower lobe on chest radiograph. Fiberoptic bronchoscopy revealed obstruction of the right superior segment of the lower bronchus with an exophytic endobronchial mass. Endobronchial actinomycosis was confirmed by demonstration of sulfur granules in the bronchoscopic biopsy of the mass. Intravenous administration of penicillin G followed by oral amoxacillin/clavulanic acid therapy for 3 months resulted in improving symptoms. Infiltrative consolidation on the chest X-ray was markedly decreased.

Entities:  

Mesh:

Year:  2000        PMID: 11242814      PMCID: PMC4531766          DOI: 10.3904/kjim.2000.15.3.240

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  14 in total

1.  Thoracic actinomycosis.

Authors:  M BATES; G CRUICKSHANK
Journal:  Thorax       Date:  1957-06       Impact factor: 9.139

2.  Visceral actinomycosis.

Authors:  V Z COPE
Journal:  Br Med J       Date:  1949-12-10

3.  Pulmonary actinomycosis.

Authors:  P Frank; B Strickland
Journal:  Br J Radiol       Date:  1974-07       Impact factor: 3.039

4.  Human actinomycosis. A study of 181 subjects.

Authors:  J R Brown
Journal:  Hum Pathol       Date:  1973-09       Impact factor: 3.466

5.  Endobronchial actinomycosis.

Authors:  M Lee; H W Berger; N A Fernandez; S Tawney
Journal:  Mt Sinai J Med       Date:  1982 Mar-Apr

6.  A study of 57 cases of actinomycosis over a 36-year period. A diagnostic 'failure' with good prognosis after treatment.

Authors:  W C Weese; I M Smith
Journal:  Arch Intern Med       Date:  1975-12

Review 7.  Actinomycosis: diagnostic and therapeutic considerations and a review of 32 cases.

Authors:  D F Bennhoff
Journal:  Laryngoscope       Date:  1984-09       Impact factor: 3.325

8.  Thoracic actinomycosis: CT findings in eight patients.

Authors:  J S Kwong; N L Müller; J D Godwin; D Aberle; M R Grymaloski
Journal:  Radiology       Date:  1992-04       Impact factor: 11.105

9.  Endobronchial actinomycosis simulating bronchogenic carcinoma. Diagnosis by bronchial biopsy.

Authors:  I Ariel; R Breuer; N S Kamal; I Ben-Dov; P Mogel; E Rosenmann
Journal:  Chest       Date:  1991-02       Impact factor: 9.410

10.  Endobronchial actinomycosis simulating endobronchial tuberculosis: a case report.

Authors:  S H Lee; J J Shim; E Y Kang; S Y Lee; J Y Jo; K H In; S H Yoo; K H Kang
Journal:  J Korean Med Sci       Date:  1999-06       Impact factor: 2.153

View more
  3 in total

1.  A case of endobronchial actinomycosis as a challenging cause of lung atelectasis.

Authors:  Nicoletta Golfi; Roberta Mastriforti; Luca Guidelli; Raffaele Scala
Journal:  BMC Infect Dis       Date:  2021-05-08       Impact factor: 3.090

2.  A case of pulmonary actinomycosis presented with endobronchial involvement.

Authors:  Petros Oikonomidis; Fotios Fousekis; Panagiotis Kotsaftis; Ioannis Pilios; Dionysios Dimas; Georgios Giannoulis
Journal:  Respir Med Case Rep       Date:  2019-08-29

3.  An overview of thoracic actinomycosis: CT features.

Authors:  Ji-Yeon Han; Ki-Nam Lee; Jae Kyo Lee; Yun Hyeon Kim; Seok Jin Choi; Yeon Ju Jeong; Mee-Sook Roh; Pil Jo Choi
Journal:  Insights Imaging       Date:  2012-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.